Morning Overview on MSN
The FDA approved a Pfizer RSV vaccine for at-risk adults as young as 18
Adults between 18 and 59 who face elevated risk of severe respiratory syncytial virus infection now have a licensed vaccine ...
Prognostic Factors in Pancreatic Endocrine Neoplasms: An Analysis of 136 Cases With a Proposal for Low-Grade and Intermediate-Grade Groups PURPOSE: The HER-2/neu protein is a nonmutated tumor antigen ...
Tony Wood, Chief Scientific Officer, GSK: “We are pleased with ACIP's recommendation to expand the benefits of RSV immunization to more than 13 million adults aged 50-59 who are at increased risk for ...
Experts in vaccines and vaccination—including pediatricians—work together throughout the year to update the Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger. The ...
The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...
In the 1880's and 1890's, Robert Koch established that a different microbe causes each infectious disease. Koch defined a process by which a specific causative organism could be identified by ...
KENILWORTH, N.J. & BRIDGEWATER, N.J.--(BUSINESS WIRE)--VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results